金城医药(300233.SZ)：拟转让药品生产技术及上市许可持有人权益

Core Viewpoint - Jincheng Pharmaceutical's subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., plans to transfer its rights to the production technology and marketing authorization of "Progesterone Vaginal Soft Capsules" to Haimerni (Shanghai) Pharmaceutical Technology Co., Ltd. for a total fee of RMB 50 million [1] Group 1 - The transfer involves the production technology and marketing rights of "Progesterone Vaginal Soft Capsules" (brand name: Langyigeng Baofen) [1] - The total transaction fee is RMB 50 million, which has been agreed upon by both parties after considering the actual value of the product rights and market conditions [1]